Keyphrases
Angiotensin II (Ang II)
25%
Antihypertensive Drugs
37%
Arterial Compliance
44%
Arterial Elasticity
54%
Artery Elasticity
25%
Aspirin
36%
Atrial Fibrillation
38%
Blood Pressure
85%
Blood Pressure Measurement
23%
Cardiac Output
23%
Cardiovascular Disease
30%
Cardiovascular Events
28%
Cardiovascular Mortality
29%
Cardiovascular Outcomes
22%
Cardiovascular Risk
41%
Cilazapril
23%
Confidence Interval
32%
Coronary Artery Disease
26%
Cytosolic Calcium
35%
Diabetes
25%
Diastolic Blood Pressure
34%
Dysglycemia
25%
Elasticity Index
26%
Endothelin-1 (ET-1)
24%
Essential Hypertension
55%
Hazard Ratio
32%
Heart Failure
50%
Heart Rate
24%
Hemodynamic Effects
32%
Hyperinsulinemia
26%
Hypertension
67%
Hypertension Management
41%
Hypertensive Patients
46%
Insulin
37%
Israel
37%
Large Arteries
41%
Laser Doppler Flowmetry
23%
Mean Arterial Pressure
33%
Metabolic Parameters
24%
Moderate to Severe
25%
Placebo
62%
Randomized Placebo-controlled Trial
24%
Rivaroxaban
28%
Small Arteries
25%
Small Artery Elasticity
26%
Spontaneously Hypertensive Rats
31%
Systemic Vascular Resistance
32%
Systolic Blood Pressure
38%
Type 2 Diabetes Mellitus (T2DM)
32%
Type 2 Diabetic Patients
23%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
41%
Amlodipine
13%
Angiotensin
14%
Angiotensin II
25%
Angiotensin Receptor Antagonist
26%
Antihypertensive Agent
69%
Atorvastatin
15%
Atrial Fibrillation
35%
Beta Adrenergic Receptor Blocking Agent
15%
Bleeding
15%
Calcium Channel Blocker
17%
Calcium Ion
38%
Candesartan
15%
Cardiovascular Disease
37%
Cardiovascular Risk
29%
Catecholamine
37%
Cerebrovascular Accident
48%
Cilazapril
23%
Congestive Heart Failure
50%
Coronary Artery Disease
24%
Deoxyglucose
19%
Dipeptidyl Carboxypeptidase Inhibitor
24%
Dronedarone
15%
Dysglycemia
25%
Endothelin
17%
Essential Hypertension
44%
Fatty Acid
13%
Heart Infarction
24%
Hypercholesterolemia
12%
Hyperinsulinemia
15%
Hyperlipidemia
15%
Insulin Glargine
19%
Ischemic Heart Disease
16%
Isoprenaline
17%
Ketanserin
15%
Losartan
17%
Metabolic Syndrome X
17%
Non Insulin Dependent Diabetes Mellitus
43%
Noradrenalin
47%
Omega-3 Fatty Acid
17%
Peripheral Occlusive Artery Disease
17%
Phosphatidylinositide
14%
Placebo
100%
Rivaroxaban
28%
Rosiglitazone
15%
Side Effect
14%
Simvastatin
15%
Spontaneously Hypertensive Rat
23%
Tumor Necrosis Factor
16%
Vascular Disease
16%
Medicine and Dentistry
Acetylsalicylic Acid
16%
Adenosine
11%
Apoplexy
11%
Arm
10%
Arterial Stiffness
15%
Artery Compliance
35%
Atrial Fibrillation
13%
Blood Pressure
71%
Body Mass Index
12%
Breathing
15%
Calcium Channel Blocking Agent
15%
Calcium Ion
21%
Capillary Flow
13%
Cardiac Muscle Cell
13%
Cardiology
19%
Cardiovascular Disease
22%
Cardiovascular Risk
22%
Cardiovascular System
37%
Congestive Heart Failure
29%
Deoxyglucose
19%
Diabetes
23%
Diastolic Blood Pressure
26%
Dysglycemia
17%
Essential Hypertension
19%
Hazard Ratio
12%
Hemodynamic
35%
Hypercholesterolemia
10%
Hyperinsulinemia
18%
Insulin Glargine
17%
Isotopes of Calcium
15%
Laser Doppler Flowmetry
15%
Low-Density Lipoprotein
15%
Maturity Onset Diabetes of the Young
36%
Mean Arterial Pressure
28%
Mortality Rate
13%
Odds Ratio
10%
Opioid Receptor
11%
Patient with Type 2 Diabetes
15%
Peripheral Vascular Disease
17%
Phosphatidylinositide
14%
Placebo
36%
Pulse Wave Velocity
21%
Receptor
13%
Rivaroxaban
12%
Rosiglitazone
15%
Secretagogue
11%
Systemic Vascular Resistance
22%
Systolic Blood Pressure
26%
Thyroid Hormone
11%
Tumor Necrosis Factor
16%